|
FAM40A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.703600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.021400E-01 |
| Normal-vs-Stage2 |
6.574300E-02 |
| Normal-vs-Stage3 |
1.288470E-02 |
| Normal-vs-Stage4 |
2.847700E-02 |
| Stage1-vs-Stage2 |
2.999800E-01 |
| Stage1-vs-Stage3 |
5.108400E-02 |
| Stage1-vs-Stage4 |
2.137200E-01 |
| Stage2-vs-Stage3 |
7.075400E-01 |
| Stage2-vs-Stage4 |
8.939800E-01 |
| Stage3-vs-Stage4 |
8.019600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.629600E-02 |
| Normal-vs-AfricanAmerican |
4.241400E-01 |
| Normal-vs-Asian |
9.855200E-01 |
| Caucasian-vs-AfricanAmerican |
8.129400E-01 |
| Caucasian-vs-Asian |
1.880370E-01 |
| AfricanAmerican-vs-Asian |
4.951200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.611600E-02 |
| Normal-vs-Female |
5.952100E-02 |
| Male-vs-Female |
5.178200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.497800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.966000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.598300E-03 |
| Normal-vs-Age(81-100Yrs) |
9.493900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.618600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.015950E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.185600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.142790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.280400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.078800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.038200E-02 |
| Classical-VS-Follicular |
8.09819999947337E-08 |
| Classical-VS-Other |
2.586600E-01 |
| Classical-VS-Normal |
6.900600E-01 |
| Tall-VS-Follicular |
2.043400E-01 |
| Tall-VS-Other |
9.371000E-01 |
| Tall-VS-Normal |
2.761500E-02 |
| Follicular-VS-Other |
5.468000E-01 |
| Follicular-VS-Normal |
6.27890000000075E-05 |
| Other-VS-Normal |
1.788430E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.168100E-02 |
| Normal-vs-N1 |
9.138500E-03 |
| N0-vs-N1 |
2.638400E-01 |
|
|
